Back to top
more

Agilent Technologies (A)

(Real Time Quote from BATS)

$143.77 USD

143.77
257,591

-1.20 (-0.83%)

Updated Oct 7, 2024 01:10 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 252)

Industry: Electronics - Testing Equipment

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Agilent (A) Up 11.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Agilent Technologies (A) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.

Agilent Prices Public Offering of $500M Senior Notes Due 2029

by Zacks Equity Research

Agilent (A) prices senior notes aggregating $500 million. These notes carry an interest rate of 2.750%.

Trimble Strengthens Forestry Division With 3LOG Acquisition

by Zacks Equity Research

3LOG Systems' solutions complement will Trimble's (TRMB) Connected Forest solutions portfolio.

Simple Market Timing Strategies That Work - August 21, 2019

by Zacks Equity Research

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

Has Agilent Technologies (A) Outpaced Other Computer and Technology Stocks This Year?

by Zacks Equity Research

Is (A) Outperforming Other Computer and Technology Stocks This Year?

Agilent Launches eSight, Expands Cell Analysis Portfolio

by Zacks Equity Research

Agilent (A) unveils a multimode real-time cell analyzer, which will aid in expanding its presence in the research areas of cell biology, immunology, immuno-oncology and immunotherapy.

Tencent (TCEHY) Q2 Earnings Beat Estimates, Revenues Up Y/Y

by Zacks Equity Research

Tencent's (TCEHY) second-quarter 2019 results benefit from robust FinTech and Business Services revenues despite sluggish ad environment in China.

Agilent (A) Upgraded to Buy: Here's Why

by Zacks Equity Research

Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Agilent (A) Jumps: Stock Rises 6.1%

by Zacks Equity Research

Agilent (A) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Agilent (A) Earnings and Revenues Beat Estimates in Q3

by Zacks Equity Research

Agilent (A) reports solid fiscal third-quarter results driven by strength in all its revenue segments.

Agilent Technologies (A) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Agilent (A) delivered earnings and revenue surprises of 5.56% and 2.85%, respectively, for the quarter ended July 2019. Do the numbers hold clues to what lies ahead for the stock?

Wall Street Tumbles Following Yield Curve Inversion

by Zacks Equity Research

Wall Street Tumbles Following Yield Curve Inversion

Stock Futures Plunge as Recession Fears Intensify

by Zacks Equity Research

U.S. stock futures plummeted ahead of trading on Wednesday after a key Treasury yield curve inverted signaling an impending recession.

Agilent (A) Gears Up for Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal third-quarter 2019 results.

Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Truth About Market Timing - July 30, 2019

by Zacks Equity Research

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

Agilent to Acquire BioTek, Cell Analysis Portfolio to Expand

by Zacks Equity Research

Agilent Technologies (A) enters into an agreement to buy BioTek Instruments, which is likely to strengthen its cell analysis capabilities and expand presence in life science research space.

Sanghamitra Saha headshot

5 Top & Flop ETF Areas of Q2

by Sanghamitra Saha

Dovish Fed comments and chances of U.S.-China trade truce kept the market steady in the second quarter. These ETF areas won and lost in the second quarter.

Shilpa Mete headshot

Electronics Testing Equipment Industry Outlook Appears Bright

by Shilpa Mete

Prospects of the Electronics - Testing Equipment industry look bright, thanks to the increasing proliferation of electronic devices in every major sector.

Agilent Announces Receipt of FDA Approval for pharmDX Assay

by Zacks Equity Research

Agilent (A) receives approval on the expanded use of its PD-L1 IHC 22C3 pharmDx assay.

Why Is Agilent (A) Up 3.9% Since Last Earnings Report?

by Zacks Equity Research

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sanghamitra Saha headshot

Tense About Trade War? Follow Goldman With 5 ETF Strategies

by Sanghamitra Saha

Amid heightened US-China trade tensions, investors can land up on five ETF strategies and follow the suggestions of Goldman Sachs.

Agilent (A) Misses Earnings and Revenue Estimates in Q2

by Zacks Equity Research

Agilent (A) reports weak fiscal second-quarter results due to slowing global demand in small molecule Pharma and softness in the China Food market.

Agilent Technologies (A) Q2 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Agilent (A) delivered earnings and revenue surprises of -1.39% and -2.30%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?